Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies

Haematologica

Volumn 85, Issue 1, 2000, Pages 63-66

  Cesaro, Simone ^a,b   Bortolotti, Flavia ^a   Petris, Maria Grazia ^a   Brugiolo, Alessandra ^b   Cusinato, Riccardo ^b   Guido, Maria ^c   Rossetti, Flavio ^b   Masiero, Lucia ^a   Zanesco, Luigi ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Anatomia Patologica   (Italy)

Author keywords

Cancer; Chronic hepatitis C; Hepatitis C virus genotype; Interferon; Pediatric malignancy

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; SOLID TUMOR; VIREMIA;

ACETAMINOPHEN; ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ALOPECIA; ASTHENIA; BLOOD TRANSFUSION; CHLORPHENIRAMINE; DNA, VIRAL; FEMALE; FEVER; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; NEOPLASMS; NEUTROPENIA; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RISK FACTORS; RNA, VIRAL;

EID: 0033974455     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Locasciulli A, Alberti A, Barbieri R, et al. Evidence of non-A, non-B hepatitis in children with acute leukemia and chronic liver disease. Am J Dis Child 1983; 137:354-6.
2. Cesaro S, Petris MG, Rossetti F, et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997; 90:1315-20.
3. De Bisceglie AM. Hepatitis C. Lancet 1998; 351:351-5.
4. Poynard T, Leroy V, Cohard M, et al. Meta-analysis of Interferon randomized trials in the treatment of viral hepatitis C: effect of dose and duration. Hepatology 1996; 24:778-89.
5. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alpha-2b regimens for the long term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 1995; 332: 1457-62.
6. Marcellini M, Kondili LA, Comparcola D, et al. High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease. Pediatr Infect Dis J 1997; 16:1049-53.
7. Bortolotti F, Giacchino R, Vajro P, et al. Recombinant interferon-alpha therapy in children with chronic hepatitis C. Hepatology 1995; 22:1623-7.
8. Hoofnagle JH, di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997; 336:347-56.
9. Cesaro S, Rossetti F, De Moliner L, Crivellaro C, Zanesco L, Bortolotti F. Interferon for chronic hepatitis C in patients cured of malignancy. Eur J Pediatr 1994; 153:659-62.
10. Komatsu H, Fujisawa T, Inui A, et al. Efficacy of interferon in treating chronic hepatitis C in children with a history of acute leukemia. Blood 1996; 87:4072-5.
11. Cha TA, Beall E, Irvine B, et al. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA 1992; 89:7144-8.
12. Simmonds P, Holmes EC, Cha TA. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74:2391-9.
13. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13:372-4.
14. Aricò M, Maggiore G, Silini E, et al. Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 1994; 84:2919-22.
15. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group. Lancet 1998; 352:1426-32.
16. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1485-92.
17. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998; 339:1493-99.
18. Liang TJ. Combination therapy for hepatitis C infection. N Engl J Med 1998; 339:1549-50.